X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anticarcinogenic agents - pharmacology (5610) 5610
humans (4299) 4299
animals (4272) 4272
oncology (2257) 2257
mice (1926) 1926
male (1924) 1924
female (1767) 1767
cancer (1707) 1707
rats (1469) 1469
apoptosis (1335) 1335
anticarcinogenic agents - therapeutic use (1271) 1271
chemoprevention (1223) 1223
pharmacology & pharmacy (1176) 1176
apoptosis - drug effects (1114) 1114
cell line, tumor (1072) 1072
prevention (909) 909
biochemistry & molecular biology (787) 787
carcinogenesis (754) 754
neoplasms - prevention & control (735) 735
inhibition (726) 726
cell proliferation - drug effects (692) 692
dose-response relationship, drug (692) 692
expression (672) 672
anticarcinogenic agents - chemistry (609) 609
antioxidants - pharmacology (596) 596
toxicology (586) 586
plant extracts - pharmacology (537) 537
in-vitro (528) 528
anticarcinogenic agents - administration & dosage (518) 518
nutrition & dietetics (502) 502
tumor cells, cultured (502) 502
oxidative stress (491) 491
chemistry, medicinal (484) 484
induction (474) 474
growth (471) 471
diet (469) 469
cell division - drug effects (441) 441
activation (432) 432
signal transduction - drug effects (420) 420
cells (414) 414
rats, sprague-dawley (414) 414
carcinogens - toxicity (410) 410
catechin - pharmacology (406) 406
catechin - analogs & derivatives (399) 399
analysis (389) 389
antioxidants (388) 388
research (377) 377
breast-cancer (376) 376
carcinogens (374) 374
nf-kappa-b (372) 372
cell survival - drug effects (369) 369
food science & technology (359) 359
antineoplastic agents - pharmacology (354) 354
isothiocyanates - pharmacology (353) 353
disease models, animal (345) 345
care and treatment (338) 338
colonic neoplasms - prevention & control (338) 338
tumors (338) 338
liver - drug effects (325) 325
cell cycle - drug effects (321) 321
rats, wistar (320) 320
rats, inbred f344 (318) 318
gene-expression (317) 317
skin neoplasms - prevention & control (316) 316
blotting, western (313) 313
time factors (309) 309
health aspects (304) 304
cell line (301) 301
neoplasms - drug therapy (301) 301
isothiocyanates (297) 297
cell biology (292) 292
breast cancer (287) 287
stilbenes - pharmacology (287) 287
flavonoids - pharmacology (286) 286
proliferation (286) 286
enzymes (283) 283
polyphenols (283) 283
genistein - pharmacology (282) 282
resveratrol (280) 280
risk (280) 280
green tea (279) 279
signal transduction (272) 272
flavonoids (270) 270
sulforaphane (263) 263
gene expression regulation, neoplastic - drug effects (260) 260
in-vivo (259) 259
prostate-cancer (259) 259
indoles - pharmacology (257) 257
cell transformation, neoplastic - drug effects (256) 256
cell cycle (250) 250
proteins (249) 249
metabolism (248) 248
anticarcinogenic agents - isolation & purification (243) 243
colorectal-cancer (241) 241
antineoplastic agents, phytogenic - pharmacology (240) 240
colon cancer (238) 238
breast neoplasms - prevention & control (237) 237
phosphorylation (237) 237
cells, cultured (236) 236
thiocyanates - pharmacology (236) 236
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6776) 6776
Japanese (82) 82
Chinese (51) 51
Russian (45) 45
Polish (11) 11
French (9) 9
Hungarian (9) 9
Portuguese (9) 9
Spanish (9) 9
German (5) 5
Ukrainian (2) 2
Czech (1) 1
Dutch (1) 1
Italian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Trends in molecular medicine, ISSN 1471-4914, 2012, Volume 18, Issue 6, pp. 337 - 347
Glucosinolates and isothiocyanates have both been objects of research for more than half a century. Interest in these unique phytochemicals escalated following... 
Pathology | PHENETHYL ISOTHIOCYANATE | MEDICINE, RESEARCH & EXPERIMENTAL | MIGRATION INHIBITORY FACTOR | BIOCHEMISTRY & MOLECULAR BIOLOGY | BENZYL ISOTHIOCYANATE | CRUCIFEROUS VEGETABLES | SULFORAPHANE RESTORES | CELL BIOLOGY | TRANSCRIPTION FACTOR NRF2 | TRAUMATIC BRAIN-INJURY | INTRACEREBRAL HEMORRHAGE | SPINAL-CORD-INJURY | BROCCOLI SPROUT BEVERAGES | Cardiovascular Diseases - drug therapy | Humans | Isothiocyanates - administration & dosage | Diabetic Nephropathies - drug therapy | Glucosinolates - chemistry | Neuroprotective Agents - pharmacology | Anticarcinogenic Agents - administration & dosage | Isothiocyanates - chemistry | Anti-Bacterial Agents - chemistry | Helicobacter Infections - drug therapy | Models, Animal | Neuroprotective Agents - administration & dosage | Anticarcinogenic Agents - pharmacology | Isothiocyanates - pharmacology | Neuroprotective Agents - chemistry | Cardiotonic Agents - chemistry | Cardiotonic Agents - pharmacology | Animals | Anticarcinogenic Agents - chemistry | Cardiotonic Agents - administration & dosage | Glucosinolates - pharmacology | Central Nervous System - drug effects | Anti-Bacterial Agents - pharmacology | Cell Transformation, Neoplastic - drug effects | Anti-Bacterial Agents - administration & dosage | Glucosinolates - administration & dosage | Skin - drug effects | Proteins | Analysis
Journal Article
Journal Article
Journal Article
Journal Article
International journal of molecular sciences, ISSN 1422-0067, 2016, Volume 17, Issue 3, pp. 290 - 290
Cancer, being the second leading cause of mortality, exists as a formidable health challenge. In spite of our enormous efforts, the emerging complexities in... 
Chemotherapy | Chemoprevention | Phytochemical | Withaferin-A | Cancer | withaferin-A | COMPOUND WITHAFERIN | INDUCED APOPTOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | DOWN-REGULATION | STEROIDAL LACTONE | chemotherapy | CHEMISTRY, MULTIDISCIPLINARY | BREAST-CANCER CELLS | chemoprevention | PROTECTIVE ROLE | IN-VIVO | WITHANIA-SOMNIFERA ROOT | cancer | MELANOMA-CELLS | NF-KAPPA-B | phytochemical | Apoptosis - drug effects | Withanolides - chemistry | Humans | Neoplasm Invasiveness - prevention & control | Neoplasm Invasiveness - pathology | Neoplasm Metastasis - prevention & control | Angiogenesis Inhibitors - therapeutic use | Anti-Inflammatory Agents - therapeutic use | Antineoplastic Agents, Phytogenic - therapeutic use | Anticarcinogenic Agents - pharmacology | Anticarcinogenic Agents - therapeutic use | Anti-Inflammatory Agents - pharmacology | Angiogenesis Inhibitors - pharmacology | Antineoplastic Agents, Phytogenic - chemistry | Neoplasms - blood supply | Neoplasms - drug therapy | Cell Movement - drug effects | Animals | Anti-Inflammatory Agents - chemistry | Anticarcinogenic Agents - chemistry | Withanolides - pharmacology | Neoplasm Metastasis - pathology | Cell Proliferation - drug effects | Antineoplastic Agents, Phytogenic - pharmacology | Neoplasms - pathology | Withanolides - therapeutic use | Angiogenesis Inhibitors - chemistry | Withania - chemistry | Signal transduction | Phytochemicals
Journal Article
Annals of the New York Academy of Sciences, ISSN 0077-8923, 10/2012, Volume 1271, Issue 1, pp. 58 - 67
... ( cis ‐diamminedichloroplatinum (CDDP)) and its platinum derivatives are first‐line chemotherapeutic agents in the treatment of ovarian cancer. CDDP induces... 
functional food compounds | PPM1D | ovarian cancer chemoresistance | p53 | PI3K/Akt | Functional food compounds | Ovarian cancer chemoresistance | P53 | X-LINKED INHIBITOR | DNA-DAMAGE RESPONSE | MULTIDISCIPLINARY SCIENCES | CISPLATIN RESISTANCE | ONCOGENIC PHOSPHATASE WIP1 | PROTEIN-KINASE B | AKT PHOSPHORYLATION | TUMOR-SUPPRESSOR | OVER-EXPRESSION | NF-KAPPA-B | CELL HOMEOSTASIS | Apoptosis - drug effects | Humans | Phosphoprotein Phosphatases - metabolism | Drug Resistance, Neoplasm | Antineoplastic Agents - therapeutic use | Anticarcinogenic Agents - metabolism | Protein Kinase Inhibitors - adverse effects | Molecular Targeted Therapy | Antineoplastic Agents - metabolism | Antineoplastic Agents - adverse effects | Female | Anticarcinogenic Agents - adverse effects | Antineoplastic Agents - pharmacology | Antineoplastic Agents, Phytogenic - metabolism | Ovarian Neoplasms - metabolism | Antineoplastic Agents, Phytogenic - therapeutic use | Proto-Oncogene Proteins c-akt - metabolism | Anticarcinogenic Agents - pharmacology | Ovarian Neoplasms - drug therapy | Anticarcinogenic Agents - therapeutic use | Antineoplastic Agents, Phytogenic - adverse effects | Cell Survival - drug effects | Ovarian Neoplasms - prevention & control | Protein Phosphatase 2C | Tumor Suppressor Protein p53 - metabolism | Food, Fortified | Functional Food | Animals | Signal Transduction - drug effects | Protein Kinase Inhibitors - therapeutic use | Protein Kinase Inhibitors - pharmacology | DNA Damage | Antineoplastic Agents, Phytogenic - pharmacology | Proto-Oncogene Proteins c-akt - antagonists & inhibitors | Protein Kinase Inhibitors - metabolism | Ovarian cancer | Apoptosis | Side effects | Pathways | Derivatives | Survival | Suppressors | Tumors | Cancer | PI3K | Akt | Original
Journal Article
Journal Article